NANI KANEN: Open Payments
NPI 1548358435 · BURLINGAME, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,206 in 104 payments from 25 companies in 2025. Trend: 2023 $2,025 · 2024 $2,474 · 2025 $2,206
Food & beverage: $2,206
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $293 |
| Lilly USA, LLC | 12 | $291 |
| AstraZeneca Pharmaceuticals LP | 10 | $258 |
| ABBVIE INC. | 14 | $232 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $134 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $117 |
| GlaxoSmithKline, LLC. | 5 | $115 |
| PFIZER INC. | 5 | $92 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Indivior Inc. | 3 | $69 |
Products named: MOUNJARO, AIRSUPRA, CAPLYTA, VRAYLAR, TRINTELLIX, Wegovy, Rybelsus, BREZTRI.
Industry payments across CA — which companies pay providers there.
